The exploitation of beidellite clay (BDT), used as a nanofiller in the preparation of poly(butylene succinate) (PBS)/organoclay biodegradable nanocomposites, was investigated. A series of bionanocomposites with various loadings of the organoclay (3CTA-BDT) were prepared by in situ polycondensation reaction between succinic anhydride (SuAh) and 1,4-butanediol (1,4-BD) at atmospheric pressure in refluxing decalin with azeotropic removal of water, and the reaction was catalyzed by non-toxic bismuth chloride (BiCl₃). X-ray diffraction (XRD) and scanning electron microscopy (SEM) results showed that 3CTA-BDT was likely exfoliated and well dispersed in PBS matrix. Thermal properties (TGA, DSC and thermal conductivity), contact angle measurements and water vapor sorption behavior of the corresponding nanocomposites were also discussed. Compared to pure PBS, a significant reduction of the diffusion coefficient and the water vapor permeability (WVP) by 44 and 37%, respectively, was observed by adding only 5 wt% of 3CTA-BDT. These results could make these bionanocomposites suitable materials for food packaging application.

Osteochondral defect repair with a collagen/collagen-magnesium-hydroxyapatite (Col/Col-Mg-HAp) scaffold has demonstrated good clinical results. However, subchondral bone repair remained suboptimal, potentially leading to damage to the regenerated overlying neocartilage. This study aimed to improve the bone repair potential of this scaffold by incorporating newly developed strontium (Sr) ion enriched amorphous calcium phosphate (Sr-ACP) granules (100–150 μm). Sr concentration of Sr-ACP was determined with ICP-MS at 2.49 ± 0.04 wt%. Then 30 wt% ACP or Sr-ACP granules were integrated into the scaffold prototypes. The ACP or Sr-ACP granules were well embedded and distributed in the collagen matrix demonstrated by micro-CT and scanning electron microscopy/energy dispersive x-ray spectrometry. Good cytocompatibility of ACP/Sr-ACP granules and ACP/Sr-ACP enriched scaffolds was confirmed with in vitro cytotoxicity assays. An overall promising early tissue response and good biocompatibility of ACP and Sr-ACP enriched scaffolds were demonstrated in a subcutaneous mouse model. In a goat osteochondral defect model, significantly more bone was observed at 6 months with the treatment of Sr-ACP enriched scaffolds compared to scaffold-only, in particular in the weight-bearing femoral condyle subchondral bone defect. Overall, the incorporation of osteogenic Sr-ACP granules in Col/Col-Mg-HAp scaffolds showed to be a feasible and promising strategy to improve subchondral bone repair.